Usama Hussain Kamal

Dr. Usama Hussain Kamal

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2024 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
UKUsama Hussain Kamal
Usama Hussain Kamal
AJAdeena Mbbs Jamil
Adeena Mbbs Jamil
EFEeshal Mbbs Fatima
Eeshal Mbbs Fatima
AKAbiha Mbbs Khurram
Abiha Mbbs Khurram
ZKZoha Mbbs Khan
Zoha Mbbs Khan
MJMichael Jaglal
Michael Jaglal
Objectives: Esophageal cancer (EC) is the sixth leading cause of cancer-related deaths in the United States, with a mere 20% survival rate in the first 5 years, making it a significant public health concern. Considering the lack of comprehensive evaluations of mortality trends, this study aims to provide an update on the mortality rates of esophageal cancer and its trends in the United States. Methods: The mortality trends among adults with EC were analyzed using data from the CDC WONDER database. Crude and age-adjusted mortality rates (AAMRs) per 100,000 people were extracted. Annual percent changes (APCs) in AAMRs with 95% CI were obtained using joinpoint regression analysis across different demographic (sex, race/ethnicity, and age) and geographic (state, urban-rural, and regional) subgroups. Results: Between 1999 and 2020, 309,725 documented deaths were attributed to esophageal cancer. The overall AAMR decreased from 1999 to 2020 (6.69 to 5.68). Males had higher consistently higher AAMRs than females (10.96 vs. 2.24). NH White had the highest overall AAMR (6.88), followed by NH Black (6.46), NH American Indian (4.95), Hispanic or Latino (3.31), and NH Asian or Pacific Islander (2.57). AAMR also varied by region (overall AAMR: Midwest: 7.18; Northeast: 6.75; South: 6.07; West: 5.76), and nonmetropolitan areas had higher AAMR (non-core areas: 7.09; micropolitan areas: 7.19) than metropolitan areas (large central metropolitan areas: 5.75; large fringe areas: 6.33). The states in the upper 90th percentile of esophageal cancer-related AAMR were Vermont, District of Columbia, West Virginia, Ohio, New Hampshire, and Maine, and exhibited an approximately two-fold increase in AAMRs, compared with states falling in the lower 10th percentile. Conclusions: Over the last 2 decades, there has been an overall decline in mortality related to EC in the United States. However, demographic and geographic discrepancies in EC-related mortality persist, necessitating additional exploration and development of specifically directed treatments.

14 February 2025 in International Journal of Cardiology Cardiovascular Risk and Prevention
Verified
Journal Article
Open access
EAEman Ali
Eman Ali
HRHafsah Alim Ur Rahman
Hafsah Alim Ur Rahman
UKUsama Hussain Kamal
Usama Hussain Kamal
MFMuhammad Ahmed Ali Fahim
Muhammad Ahmed Ali Fahim
MSMadiha Salman
Madiha Salman
MAM. Chadi Alraies
M. Chadi Alraies
Lung cancer remains the leading cause of cancer-related mortality in the United States and shares cardiovascular risk factors with chronic ischemic heart disease (CIHD). However, the cumulative mortality burden of these comorbid conditions is underexplored. This study aims to retrospectively assess mortality trends among American adults with concurrent lung cancer and CIHD. We utilized death certificate data from the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database, encompassing ICD-10 codes for individuals aged ≥45 years from 1999 to 2020. Age-adjusted mortality rates (AAMRs) per 100,000 population, annual percentage change (APC), and corresponding 95 % confidence intervals (CIs) were calculated. Data were further stratified by year, sex, race, and geographic region (state, rural-urban, and census regions). A total of 214,785 deaths were identified in adults aged ≥45 years with comorbid lung cancer and CIHD. The overall AAMR between 1999 and 2020 was 8.4 per 100,000 (95 % CI: 8.3 to 8.4). AAMRs remained relatively stable from 1999 to 2005 (APC: −0.84 %; 95 % CI: −1.91 to 1.54), followed by a significant decline from 2005 to 2010 (APC: −2.37 %; 95 % CI: −5.58 to −0.61) and from 2010 to 2017 (APC: −4.72 %; 95 % CI: −7.61 to −3.60). A subsequent period of stability was noted between 2017 and 2020 (APC: 0.86 %; 95 % CI: −2.17 to 5.22). In 1999, men had a threefold higher mortality rate compared to women (AAMR: 17.8 vs. 5.7), with a non-significant decline by 2020 (AAMR: 10 vs. 4). Stratification by race/ethnicity revealed that non-Hispanic (NH) Whites exhibited the highest AAMR at 9.3, followed by NH American Indian or Alaska Natives (7.3), NH Blacks (6.8), Hispanic/Latinos (3.3), and NH Asians or Pacific Islanders (3.2). Geographically, AAMRs were highest in the Midwest (9.6), followed by the Northeast (8.8), South (8.4), and West (6.8). Non-metropolitan regions exhibited higher AAMRs compared to metropolitan areas (10.3 vs. 8.0). States in the top 90th percentile, such as West Virginia, Kentucky, Vermont, Ohio, and Rhode Island, had nearly triple the AAMRs compared to states in the lower 10th percentile, including Utah, Nevada, Arizona, New Mexico, and Hawaii. From 1999 to 2020, mortality rates for adults aged ≥45 years with concurrent lung cancer and CIHD declined. The highest AAMRs were observed among men, NH Whites, individuals residing in the Midwest, and non-metropolitan populations. This highlights the need for a more comprehensive and tailored approach to managing these patients moving forward.

20 May 2025 in JGH Open
Verified
Journal Article
Open access
MNMuhammad Ahmad Nadeem
Muhammad Ahmad Nadeem
AKAbdullah Khan
Abdullah Khan
ARAhsan Raza Raja
Ahsan Raza Raja
UKUsama Hussain Kamal
Usama Hussain Kamal
AAAbdul Rafeh Awan
Abdul Rafeh Awan
ASAmir Humza Sohail
Amir Humza Sohail
Objectives: Intrahepatic cholangiocarcinoma (ICC) is a malignancy with rising incidence and mortality in the United States. This study aimed to investigate temporal trends in the place of death among patients with ICC and assess demographic disparities.Methods: We used the CDC WONDER database (2003–2020) for a retrospective study of patients who died from intrahepatic cholangiocarcinoma identified through death certificates. Place of death was categorized as hospice, home, inpatient, nursing home, or other. Age‐adjusted mortality rates were calculated per 100 000. Temporal trends were assessed using the Mann‐Kendall trend test, and associations between demographic characteristics and place of death were examined using the χ2 test.Results: Of 101 631 ICC‐related deaths (AAMR: 1.61; 95% CI 1.60–1.62), the AAMR rose from 1.19 (95% CI 1.15–1.23) in 2003 to 2.04 (95% CI 2.00–2.08) in 2020. Over the study period, home was the most frequent place of death (44.6%), followed by inpatient facilities (28.4%), hospice (11.1%), and nursing homes (9.5%). Deaths at home and in hospice increased significantly (p < 0.01), while inpatient and nursing home deaths declined (p < 0.01). Disparities were observed across race, sex, age groups, and urbanization. Younger patients more often died in inpatient facilities, and minority racial groups were less likely to die at home or utilize hospice.Conclusions: ICC‐related deaths in the USA nearly doubled over the study period, with a marked shift from inpatient and nursing home deaths to hospice and home. Demographic disparities in end‐of‐life care underscore the need for targeted interventions to improve equitable access to palliative services.

11 August 2026 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
AAAymen Ahmed
Aymen Ahmed
MSMuteia Shakoor
Muteia Shakoor
UKUsama Hussain Kamal
Usama Hussain Kamal
HSHiba Sohail
Hiba Sohail
MMMuhammad Hasnain Mankani
Muhammad Hasnain Mankani
MRMark J. Ricciardi
Mark J. Ricciardi
Aortic stenosis (AS) remains a leading cause of cardiovascular death, yet temporal mortality trends specifically among older adults remain poorly characterized. This study analyzed trends and disparities in AS-related mortality among older adults in the United States from 1999 to 2024. Using the CDC WONDER database, we analyzed AS-related deaths among adults aged ≥65 years. Age-adjusted mortality rates (AAMR) and average annual percent change (AAPC) were calculated across demographic and geographic subgroups. A total of 637,178 deaths were recorded. The overall AAMR for AS-related mortality decreased significantly from 1999 (55.74) to 2024 (52.46) (AAPC, -0.23; P =.004). Although rates rose from 2018 to 2021, a significant decline followed through 2024 (annual percent change, -2.40). Men had consistently higher AAMR than women; mortality remained stable in men (AAPC, -0.06; P = .33), but declined among women (AAPC, -0.35; P =.002). AS-related mortality decreased among patients aged 75 to 84 years, but increased in those ≥85 years (AAPC, 0.28), who had the highest AAMR throughout. Mortality declined in all census regions except for the Midwest, reaching the highest AAMR in 2024 (60.91). Nonmetropolitan areas saw increasing trends, whereas metropolitan areas saw declines. AAMR remained highest among non-Hispanic (NH) White individuals; however, significant decreases were observed in Hispanic/Latino and NH Asian/Pacific Islander populations. Aortic stenosis-related mortality declined modestly among older adults from 1999 to 2024. However, notable demographic and regional disparities persisted, including higher mortality in men, NH White individuals, older adults ≥85 years, and residents of nonmetropolitan regions and the Midwest. Further investigation and targeted interventions are needed to improve outcomes.